Abbott (23) | ![]() |
Amgen (10) | ![]() |
Astra-merck (6) | ![]() |
Bayer (41) | ![]() |
Boehringer-ingelheim (1) | ![]() |
Bristol-myers-squibb (5) | ![]() |
Dupont-merck (14) | ![]() |
Eli lilly (5) | ![]() |
Genentech (5) | ![]() |
Genzyme (5) | ![]() |
Glaxosmithkline (26) | ![]() |
Hoechst-marion-roussel (4) | ![]() |
Pasteur-merieux (8) | ![]() |
Pfizer (22) | ![]() |
Pharmaceutical industry (36) | ![]() |
Pharmaceutical laboratory (1) | ![]() |
Pharmacyclics (1) | ![]() |
Roche pharmaceuticals (16) | ![]() |
Sanofi-aventis (6) | ![]() |
Stallergenes (1) | ![]() |
Whitehall laboratories (3) | ![]() |
Chris Corrigan lectures for Glaxosmithkline and Allergy Therapeutics and consults for Novartis Stallergenes and Allergy Therapeutics.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011